Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

The prescription drug abuse epidemic.

Yu HY.

Clin Lab Med. 2012 Sep;32(3):361-77. doi: 10.1016/j.cll.2012.06.006. Review.

PMID:
22939296
2.

Prescription drug abuse: insight into the epidemic.

Hernandez SH, Nelson LS.

Clin Pharmacol Ther. 2010 Sep;88(3):307-17. doi: 10.1038/clpt.2010.154. Epub 2010 Aug 4. Review.

PMID:
20686478
3.

The nonmedical use of prescription drugs by adolescents.

Rogers PD, Copley L.

Adolesc Med State Art Rev. 2009 Apr;20(1):1-8, vii. Review.

PMID:
19492687
4.

National drug control policy and prescription drug abuse: facts and fallacies.

Manchikanti L.

Pain Physician. 2007 May;10(3):399-424. Review.

5.

Committee opinion no. 538: nonmedical use of prescription drugs.

Committee on Health Care for Underserved Women, The American College of Obstetricians and Gynecologists.

Obstet Gynecol. 2012 Oct;120(4):977-82.

PMID:
22996128
7.

Prescription drug abuse: an epidemic dilemma.

DuPont RL.

J Psychoactive Drugs. 2010 Jun;42(2):127-32. Review.

PMID:
20648908
8.

Nonmedical use of prescription medications among adolescents in the United States: a systematic review.

Young AM, Glover N, Havens JR.

J Adolesc Health. 2012 Jul;51(1):6-17. doi: 10.1016/j.jadohealth.2012.01.011. Epub 2012 Apr 4. Review.

PMID:
22727071
9.

Neuropsychiatric effects of prescription drug abuse.

Caplan JP, Epstein LA, Quinn DK, Stevens JR, Stern TA.

Neuropsychol Rev. 2007 Sep;17(3):363-80. Epub 2007 Aug 16. Review.

PMID:
17701457
10.

Social and legal factors related to drug abuse in the United States and Japan.

Greberman SB, Wada K.

Public Health Rep. 1994 Nov-Dec;109(6):731-7. Review.

11.

Development of tamper deterrent formulations: state of the pharmaceutical industry.

Hamed E, Moe D.

Curr Drug Abuse Rev. 2010 Sep;3(3):139-46. Review.

PMID:
21054261
12.

"Pharming": the abuse of prescription and over-the-counter drugs in teens.

Levine DA.

Curr Opin Pediatr. 2007 Jun;19(3):270-4. Review.

PMID:
17505185
13.

Misuse of "study drugs:" prevalence, consequences, and implications for policy.

Sussman S, Pentz MA, Spruijt-Metz D, Miller T.

Subst Abuse Treat Prev Policy. 2006 Jun 9;1:15. Review.

14.

Menstrual cycle phase and responses to drugs of abuse in humans.

Terner JM, de Wit H.

Drug Alcohol Depend. 2006 Sep 1;84(1):1-13. Epub 2006 Jan 18. Review.

PMID:
16413143
15.

Drug interactions between common illicit drugs and prescription therapies.

Lindsey WT, Stewart D, Childress D.

Am J Drug Alcohol Abuse. 2012 Jul;38(4):334-43. doi: 10.3109/00952990.2011.643997. Epub 2012 Jan 5. Review.

PMID:
22221229
16.

Epidemiology of stimulant misuse and abuse: implications for future epidemiologic and neuropharmacologic research.

Gerlach KK, Dasgupta N, Schnoll SH, Henningfield JE.

Neuropharmacology. 2014 Dec;87:91-6. doi: 10.1016/j.neuropharm.2014.04.020. Epub 2014 May 9. Review.

PMID:
24813641
17.

2012 Update in addiction medicine for the generalist.

Rastegar DA, Kunins HV, Tetrault JM, Walley AY, Gordon AJ; US Society of General Internal Medicine's Substance Abuse Interest Group.

Addict Sci Clin Pract. 2013 Mar 13;8:6. doi: 10.1186/1940-0640-8-6. Review.

18.

[Licit and ilicit uses of medicines].

Dinis-Oliveira RJ.

Acta Med Port. 2014 Nov-Dec;27(6):755-66. Epub 2014 Dec 30. Review. Portuguese.

Supplemental Content

Support Center